The case for cytomegalovirus prophylaxis
β
David R. Snydman
π
Article
π
2006
π
John Wiley and Sons
π
English
β 104 KB
## Abstract Cytomegalovirus prevention strategies have been debated for the past decade. This review argues in favour of the prophylaxis strategy. Clinical trials comparing prophylaxis to preβemptive therapy have, thus far, had insufficient power to differentiate strategies, especially with regard